Equities
Health CareMedical Equipment and Services
  • Price (USD)206.56
  • Today's Change-0.82 / -0.40%
  • Shares traded416.41k
  • 1 Year change-23.07%
  • Beta1.1240
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel.

  • Revenue in USD (TTM)2.97bn
  • Net income in USD357.57m
  • Incorporated1943
  • Employees14.50k
  • Location
    Teleflex Inc550 E Swedesford Rd, Suite 400WAYNE 19087United StatesUSA
  • Phone+1 (610) 225-6800
  • Fax+1 (610) 948-5101
  • Websitehttps://www.teleflex.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TFX:NYQ since
announced
Transaction
value
Palette Life Sciences ABDeal completed26 Jul 202326 Jul 2023Deal completed-19.34%650.00m
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Novanta Inc881.66m72.88m5.38bn2.90k74.177.9845.066.112.022.0224.4718.800.71473.046.36304,021.405.915.466.746.3445.3643.248.277.711.914.830.34770.002.417.49-1.588.214.19--
DENTSPLY SIRONA Inc3.97bn-132.00m6.32bn15.00k--1.9229.951.59-0.6217-0.621718.6715.890.52823.005.98264,333.30-1.76-1.14-2.13-1.3252.7153.65-3.33-2.510.94673.630.3914--1.10-0.107186.11---4.549.86
Globus Medical Inc1.57bn122.87m6.87bn5.00k43.551.7325.594.381.171.1713.7229.320.4380.95574.38313,695.203.436.903.727.4565.0571.737.8314.052.72--0.09470.0053.3417.08-35.39-4.725.57--
Masimo Corp2.05bn81.50m7.19bn3.80k90.205.2640.023.511.511.5137.8425.850.65522.005.04538,973.702.618.653.2210.3149.0057.303.9812.031.223.430.3990.000.604219.00-43.21-15.9631.06--
MSA Safety Inc1.79bn58.52m7.30bn5.10k129.567.5761.154.081.431.4345.2124.590.78632.976.04350,518.802.585.083.036.0047.6745.213.287.021.486.070.383665.9117.005.65-67.41-13.664.72-1.10
Inspire Medical Systems Inc624.80m-21.15m7.31bn1.01k--12.45--11.69-0.7298-0.729821.3219.371.014.228.27618,001.00-3.41-11.27-3.84-12.6084.5484.47-3.39-13.577.17--0.00--53.1965.3252.87--148.37--
Penumbra Inc1.06bn90.95m7.81bn4.20k87.126.6266.087.382.322.3227.0030.480.72321.045.23252,029.006.212.326.912.6164.4963.908.593.173.49--0.02150.0024.9518.934,643.1668.609.64--
Stevanato Group SpA1.16bn155.00m8.57bn5.64k48.586.2435.937.420.58460.58464.354.550.58183.142.75204,995.207.81--10.81--32.28--13.42--1.0619.740.2593--10.34--1.95------
Henry Schein, Inc.12.34bn416.00m8.99bn25.00k22.202.4713.420.72863.153.1593.6728.281.294.497.47493,560.004.406.097.3110.4431.2930.043.424.400.996310.630.31330.00-2.445.55-22.68-0.145621.27--
Teleflex Inc2.97bn357.57m9.77bn14.50k27.442.2016.293.287.567.5362.8894.410.41142.206.98205,137.204.955.865.396.4255.3755.0412.0214.621.297.780.290115.846.573.97-1.4712.732.510.00
Insulet Corp1.70bn206.30m11.53bn3.00k58.4615.7241.336.802.822.8222.7810.480.70141.436.00565,700.008.532.7110.263.1468.3565.8112.164.282.6240.740.6590.0030.0224.664,384.78128.77-7.63--
Shockwave Medical Inc730.23m147.28m12.28bn1.47k84.8818.1277.9316.823.863.8619.1318.080.661.047.86497,431.9013.3110.2914.4011.3986.9484.6920.1715.1410.7319.700.52260.0049.11126.45-31.81--72.88--
Data as of Apr 19 2024. Currency figures normalised to Teleflex Inc's reporting currency: US Dollar USD

Institutional shareholders

63.71%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Investment Management, Inc.as of 31 Dec 20237.04m14.96%
The Vanguard Group, Inc.as of 31 Dec 20235.26m11.17%
Janus Henderson Investors US LLCas of 31 Dec 20234.82m10.25%
BlackRock Fund Advisorsas of 31 Dec 20232.71m5.76%
Wellington Management Co. LLPas of 31 Dec 20232.50m5.31%
Atlanta Capital Management Co. LLCas of 31 Dec 20232.21m4.70%
SSgA Funds Management, Inc.as of 31 Dec 20232.07m4.39%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 20231.61m3.42%
Geode Capital Management LLCas of 31 Dec 20231.03m2.20%
Cooke & Bieler LPas of 31 Dec 2023734.97k1.56%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.